• 검색 결과가 없습니다.

Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies

N/A
N/A
Protected

Academic year: 2021

Share "Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies"

Copied!
9
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 1. US Incidence and mortality for female solid tumors: 2009 1 Disease site New cases Deaths Lethality
Table 2. US NCI registered single agent phase II trials of VEGF inhibitors in recurrent gynecologic cancers
Table 3. Phase II trials of VEGF neutralizing single agent therapy in patients with epithelial ovarian and primary peritoneal cancer
Table 4. National Cancer Institute registered trials of VEGF inhibitors in combination with cytotoxic agents for recurrent gynecologic cancers
+2

참조

관련 문서

ƒ 유도 핵반응은 자발적인 핵분열 (Spontaneous Nuclear Reaction)과는 달리 다른 물질과의 작 용으로 원자가 반응하여 여러 가지 생성물을 만들어

Anoxic

ƒ 임계 에너지는 핵분열 하는 핵종에 따라서 다르므로 중성자를 흡수했다 해서 모든 핵종이 핵분열을 일으키는 것은 아님.. 235 U와 같이 정지상태의 중 성자를

Results: 44 of 1048 patients with gastric cancer(4.1%) had synchronous and metachronous cancers. The average time interval between gastric cancer and secondary primary cancer

In addition, the expression of REDD1 was increased when Huh7 cells were treated with PA, and overexpression of REDD1 affected cell survival and lipid

For patients treated for chin augmentation using either genioplasty with Medpor Ⓡ or osteotomy, the predictive value of the correlation of the hard and

Objective :::: The neovascularization is an essential a factor for the growth of solid organ cancer, and especially vascular endothelial growth factor (VEGF)

마찬가지로 원자핵도 내부에 여러 에너지 준위를 가지는데, 에너지를 흡수하여 기저 상태에서 여기 상태로 전이될 수도 있고 반대로 에너지를 방출하여 여기 상태에서